Loading…
← CockpitCompetitor Analysis › 085660.KS CHA Biotech Co., Ltd.Open in the cockpit ↗

CHA Biotech Co., Ltd.085660.KSCompetitor analysis, valuation and peers

South Korea · KRW·Information Technology›Electronic Components
Momentum neutral 42
Mkt cap
$523M
US dollars, full cap
Free float
75%
of shares outstanding
$/day
$1.35M
20-day average traded
Fwd P/E
n/m
no positive forecast
ROIC−WACC
-9.6 pp
WACC 5.6%
Hurdle
n/a
no reverse DCF
Close · KRW₩7,460
1D-0.9%
1W+1.4%
1M-2.6%
3M-21.7%
6M-51.5%
YTD-49.1%
1Y-39.5%
ATR %5.7%
52w lowhigh68.8% off high

What CHA Biotech does

Employees: 354

CHA Biotech at a glance

Size CHA Biotech (085660.KS) is a South Korea Information Technology company (Electronic Components) with a market value of $523M, the 335th largest of 483 South Korea companies the cockpit tracks. Shares closed at ₩7,460 on 18 Nov 2026.

Performance Over six months the shares fell 51.5%, against -21.3% for the median peer and -37.2% for the South Korea market (cap-weighted) — 5th lowest of 21 in its peer set.

Growth Revenue grew 4.2% over the last twelve months (peer median +20.4%); the operating margin is -7.3% (peer median 3.3%).

Valuation It trades at 1.4× enterprise value to sales against a peer median of 2.7× (7th cheapest of 21).

Capital Return on invested capital runs 9.6 points below its cost of capital (5.6% WACC).

Relative performance

608010021 May 202621 Aug 202618 Nov 2026Peer median 79085660.KS 50
Six months, rebased to 100: CHA Biotech against the median of its 20 peers (local-currency closes).

CHA Biotech financials

Reported figures in KRW; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue₩1.25T₩1.27T₩1.05T₩954B₩845B
Revenue growth—+21%+10%+13%—
Gross profit₩319B₩324B₩247B₩255B₩189B
EBITDA-₩36.1B-₩854M-₩15.0B₩28.4B-₩20.9B
Net income-₩3.68B-₩110B-₩4.76B-₩8.43B-₩47.5B
Free cash flow-₩356B-₩219B-₩142B-₩62.9B-₩142B
Capital expenditure₩201B₩152B₩98.5B₩74.4B₩129B
Total debt₩786B₩831B₩759B₩450B₩401B

Quarterly statements and history in the cockpit →

CHA Biotech competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-50%0%+50%-20%0%+20%688010SENS002449FTG36056883076782SMOP231614786886093015173707001820LBIRD6269002134290550065350417200085660.KS6-month return →1-month return →
Up and to the right = strong over both horizons. CHA Biotech is the large dot.

Fundamentals: revenue growth against valuation

0%+20%+40%2×4×6×688010SENS002449FTG36056883076782SMOP231614786886093015173707001820LBIRD6269002134290550065350417200085660.KSRevenue growth (TTM) →EV / Sales →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. CHA Biotech is the large dot.

CHA Biotech competitors and peer comparison

How CHA Biotech compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

CHA Biotech against its 20 peers (data as of 18 Nov 2026)
Measure085660.KSPeer medianRank in peer set
1-month return-2.6%-11.5%6th highest of 21
6-month return-51.5%-21.3%5th lowest of 21
Distance from 52-week high-68.8%-48.0%4th lowest of 21
Revenue growth (TTM)+4.2%+20.4%5th lowest of 21
Operating margin-7.3%3.3%5th lowest of 21
EV / Sales1.4×2.7×7th cheapest of 21
ROIC minus cost of capital-9.6 pp-3.5 pp5th lowest of 20

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginEV / SalesReq gDelivered g
CHA Biotech 085660.KSSouth Korea$523M-52%+4%-7%1.4×n/an/a
Fujian Forecam Optics 688010.SSChina$532M-31%-5%-22%6.3×n/an/a
Senseonics SENSUnited States$534M+71%+105%-201%7.8×n/an/a
Foshan Nationstar Optoelectronics 002449.SZChina$542M-27%-17%-6%1.4×n/an/a
Firan Technology FTG.TOCanada$546M+56%+17%12%3.7×24.0%+13.0%
ACES Electronics 3605.TWTaiwan$501M+33%+14%6%1.4×n/an/a
Jiaxing ZMAX Optech 688307.SSChina$548M-68%+41%6%4.6×n/an/a
Visco Vision 6782.TWTaiwan$555M+41%+23%29%3.9×n/an/a
Smartoptics SMOP.OLNorway$556M-10%+45%14%5.1×16.9%+19.1%
WUS Printed Circuit 2316.TWTaiwan$556M-16%+34%-7%3.6×n/an/a
Q Technology (Group) 1478.HKHong Kong$564M-55%+31%3%0.2×n/an/a
Unionman Technology 688609.SSChina$574M-34%+18%-1%1.6×45.2%+3.4%
Shaanxi Huada Science Technology 301517.SZChina$472M-58%-9%-26%5.9×n/an/a
Episil Technologies 3707.TWOTaiwan$582M-36%+23%-3%2.6×n/an/a
Samwha Capacitor 001820.KSSouth Korea$586M+14%+5%6%2.2×31.5%+4.0%
Lumibird LBIRD.PAFrance$588M-5%+8%11%2.7×19.2%+12.2%
Flexium Interconnect 6269.TWTaiwan$592M+19%+1%-12%0.7×n/an/a
Tianjin Printronics Circuit 002134.SZChina$593M-47%+44%10%2.7×n/an/a
DK Tech 290550.KSSouth Korea$461M-10%+26%6%1.3×n/an/a
Shinsung Delta Tech 065350.KSSouth Korea$597M-43%+17%3%1.1×n/an/a
LS Materials 417200.KSSouth Korea$452M-61%+28%0%3.3×n/an/a

Questions

Which companies are CHA Biotech's closest peers?
The cockpit's peer set: Fujian Forecam Optics (688010.SS), Senseonics (SENS), Foshan Nationstar Optoelectronics (002449.SZ), Firan Technology (FTG.TO), ACES Electronics (3605.TW), Jiaxing ZMAX Optech (688307.SS), Visco Vision (6782.TW), Smartoptics (SMOP.OL).
Is CHA Biotech expensive compared with its peers?
On ev / sales it trades at 1.4× against a peer median of 2.7×, 7th cheapest of 21 in its peer set.
How has CHA Biotech stock performed?
Over six months to 18 Nov 2026 the shares returned -51.5% against -21.3% for the median peer; over one year -39.5%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.